Moreover, p53 FOXP1 has also been described as a miR-34a target, where miR-34a downregulation results in higher levels of FOXP1 and BCL6, which in turn supports DLBCL proliferation [53,54,55]. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.